Regeneron Pharmaceuticals, Inc.

MONETA GROUP INVESTMENT ADVISORS LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

427

Value ($000)

330

Weight

0.0%

2022 Q1 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	330	0.0%	427	12/31/2025
2025 Q3	11/14/2025	249	0.0%	443	9/30/2025
2025 Q2	8/14/2025	236	0.0%	450	6/30/2025
2025 Q1	5/15/2025	501	0.0%	790	3/31/2025
2024 Q4	2/11/2025	535	0.0%	751	12/31/2024
2024 Q3	11/12/2024	902	0.0%	858	9/30/2024
2024 Q2	8/13/2024	880	0.0%	837	6/30/2024
2024 Q1	8/13/2024	653	0.0%	678	3/31/2024
2023 Q4	2/15/2024	500	0.0%	569	12/31/2023
2023 Q3	11/15/2023	470	0.0%	571	9/30/2023
2023 Q2	8/15/2023	412	0.0%	574	6/30/2023
2023 Q1	5/15/2023	528	0.0%	643	3/31/2023
2022 Q4	2/16/2023	391	0.0%	516	12/31/2022
2022 Q3	11/14/2022	692	0.0%	1,005	9/30/2022
2022 Q2	8/15/2022	595	0.0%	1,007	6/30/2022
2022 Q1	5/11/2022	387	0.0%	554	3/31/2022